COR - Cencora, Inc.

Cencora, Inc. is a major player in the global pharmaceutical sourcing and distribution services sector, primarily focused on improving patient access to health products and enhancing patient care. The company distributes a diverse range of pharmaceuticals, including brand-name, specialty, and generic drugs, as well as health products and supplies to healthcare providers across various segments including acute care hospitals, retail pharmacies, and veterinary practices. Besides distribution, Cencora offers value-added services such as data analytics, pharmacy management, consulting for pharmaceutical manufacturers, and comprehensive logistics solutions.

The company's operations are divided into two reportable segments: U.S. Healthcare Solutions and International Healthcare Solutions. In the U.S., it serves as the primary supplier for diverse healthcare providers and provides specialized solutions in the oncology space and for biotechnology therapies. The International segment focuses on pharmaceutical wholesale and commercial services in Europe, leveraging its strong logistical capabilities to enhance efficiency in biopharmaceutical delivery. With its acquisition strategy, including PharmaLex and OneOncology, Cencora aims to solidify its market position and expand its service offerings, enhancing growth opportunities in both established and emerging markets.